ASHLEY FALIS: Open Payments
NPI 1730217241 · ROCKAWAY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,903 in 118 payments from 20 companies in 2025. Trend: 2023 $2,236 · 2024 $2,402 · 2025 $2,903
Food & beverage: $2,802Education: $101
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 15 | $465 |
| ABBVIE INC. | 22 | $358 |
| Amgen Inc. | 12 | $354 |
| Novartis Pharmaceuticals Corporation | 6 | $331 |
| Regeneron Healthcare Solutions, Inc. | 8 | $288 |
| UCB, Inc. | 12 | $217 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $166 |
| Galderma Laboratories, L.P. | 6 | $153 |
| Arcutis Biotherapeutics, Inc. | 1 | $125 |
| Organon LLC | 9 | $95 |
Products named: OPZELURA, SKYRIZI, Otezla, DUPIXENT, Bimzelx, NEMLUVIO, ILUMYA, Zoryve.
Industry payments across NJ — which companies pay providers there.
